1. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2022) Authors: Naccache, Jean-Marc; Jouneau, Stéphane; Didier, Morgane; Borie, Raphaël; Cachanado, Marine; Bourdin, Arnaud; Reynaud-Gaubert, Martine; Bonniaud, Philippe; Israël-Biet, Dominique; Prévot, Grégoire; Hirschi, Sandrine; Lebargy, François; Marchand-Adam, Sylvain; Bautin, Nathalie; Traclet, Julie; Gome... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation. Issue 5 (31st May 2018) Authors: Salvator, Hélène; Berti, Enora; Catherinot, Emilie; Rivaud, Elisabeth; Chabrol, Alexandre; Nguyen, Stephanie; Zemoura, Leila; Cardot, Emilie; Tcherakian, Colas; Couderc, Louis-Jean Journal: European respiratory journal Issue: Volume 51:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗